BTIG Believes Abbot (ABT) May be Renegotating Terms of Alere (ALR) Deal; Affirms at 'Buy'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Alere (ALR) Said Near Loan Deal to Waive Default on 10-K Delay - Bloomberg
April 21, 2016 5:20 PM EDTAlere (NYSE: ALR) Said Near Loan Deal to Waive Default on 10-K Delay - Bloomberg
... MoreAbbott (ABT) Declined to Comment on Alere (ALR) Beyond CEO's Comment on Call - Bloomberg
April 20, 2016 10:14 AM EDTAbbott (NYSE: ABT) Declined to Comment on Alere (NYSE: ALR) Beyond CEO's Comment on Call - Bloomberg
... MoreAlere (ALR) Pressured on Market Open After Abbott (ABT) Declines to Comment on Deal
April 20, 2016 9:45 AM EDT(Updated)
Alere (NYSE: ALR) shares were pressured on the market open Wednesday, falling 14%. Earlier Abbott (NYSE: ABT) management declined to comment on its previous agreement to acquire the company.
In March Alere received a grand jury subpoena... More
Abbott (ABT) Tops Q1 EPS by 2c; Boosts FY16 EPS Outlook
April 20, 2016 7:46 AM EDTAbbott (NYSE: ABT) reported Q1 EPS of $0.41, $0.02 better than the analyst estimate of $0.39. Revenue for the quarter came in at $4.9 billion versus the consensus estimate of $4.78 billion.
GUIDANCE:
Abbott sees FY2016 EPS of $2.14 - $2.24, versus prior guidance of $2.10 - $2.20 and... More
